90Y-DOTA-tyr3-octreotide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 90Y-DOTA-tyr3-octreotide, covering 2023-02-09 to 2023-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) [Phase 2]